Skip to main content
Crystal Denlinger, MD, Oncology, Plymouth Meeting, PA

Crystal S Denlinger MD

Gastrointestinal Cancer, Hematologic Oncology


Senior Vice President, Chief Scientific Officer, National Comprehensive Cancer Network

Join to View Full Profile
  • 3025 Chemical RdSuite 100Plymouth Meeting, PA 19462

  • Phone+1 267-622-6654

Dr. Denlinger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Provides oversight to NCCN’s Oncology Research Program and select Compendia products. Participates in NCCN policy and global initiatives. Practicing clinician with part-time voluntary faculty appointment at Fox Chase Cancer Center.

Education & Training

  • Temple University Hospital-Fox Chase Cancer Center
    Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2004 - 2007
  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2001 - 2004
  • Rutgers New Jersey Medical School
    Rutgers New Jersey Medical SchoolClass of 2001

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2004 - 2026
  • NY State Medical License
    NY State Medical License 2002 - 2004
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Fellow American College of Physicians

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors  
    David S Hong, Marwan G Fakih, Gregory A Durm, Geoffrey I Shapiro, Gerald S Falchook, Adrian Sacher, Crystal S Denlinger, John C Krauss, Andrew L Coveler, Suresh S Rama..., The New England Journal of Medicine

Lectures

  • Impact of Health Disparities on Cancer Survivorship 
    ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020

Authored Content

  • Cardiovascular Toxicity in Cancer Survivors: Current Guidelines and Future DirectionsJune 2018

Press Mentions

  • NCCN Announces Expanded Practice Guidelines for Breast Cancer with Hereditary Risks
    NCCN Announces Expanded Practice Guidelines for Breast Cancer with Hereditary RisksDecember 13th, 2024
  • NCCN Awards Grants to Improve Care for Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    NCCN Awards Grants to Improve Care for Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaDecember 4th, 2024
  • NCCN Guidelines Expanded to Meet Growing Understanding of Hereditary Risk
    NCCN Guidelines Expanded to Meet Growing Understanding of Hereditary RiskNovember 24th, 2024
  • Join now to see all

Grant Support

  • NCCN Foundation Young Investigator AwardNCCN Foundation2012–2014

Committees

  • Chair, NCCN Survivorship Guidelines Panel 2012 - Present
  • Member, Chemotherapy subcommittee, NCCN Esophagogastric Cancers Guidelines Panel 2009 - Present
  • Member, NCI Esophagogastric Task Force 2012 - 2013

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: